Curated News
By: NewsRamp Editorial Staff
August 06, 2026
Nano-X Imaging Raises $8M in Registered Direct Offering
TLDR
- Nano-X secures $8M from institutional investor, boosting capital for growth and market positioning.
- Nano-X's registered direct offering sells 8M shares with warrants at $1.00, exercisable at $1.15 for five years.
- Nano-X's funding advances affordable imaging and AI, aiming to improve preventive care and patient outcomes globally.
- Nano-X's new digital tomosynthesis system and AI tools could make medical imaging more accessible than ever before.
Impact - Why it Matters
This funding is crucial for Nanox as it advances its mission to democratize medical imaging. By securing capital, Nanox can continue developing its innovative products like the Nanox.ARC and AI-driven analytics, potentially making early disease detection more accessible and affordable. For investors, this offering signals confidence from a long-term institutional investor, which may bode well for the company's future. For the healthcare industry, Nanox's progress could lead to broader adoption of preventive imaging, ultimately improving patient outcomes and reducing healthcare costs.
Summary
Nano-X Imaging (NASDAQ: NNOX) has announced a registered direct offering with a single long-term institutional investor, aiming to raise approximately $8 million in gross proceeds. The deal involves the sale of 8 million ordinary shares (or prefunded warrants) along with warrants to purchase up to 8 million additional shares, at a combined price of $1.00 per share and warrant. The warrants have an exercise price of $1.15, become exercisable after six months, and expire in five years. The offering is expected to close around August 7, 2026, with net proceeds allocated for working capital and general corporate purposes. A.G.P./Alliance Global Partners is the sole placement agent.
Nanox is focused on advancing preventive healthcare through an integrated medical imaging platform. The company's ecosystem includes the Nanox.ARC system, a cost-effective 3D digital tomosynthesis device; Nanox.AI, which uses artificial intelligence to augment CT interpretations; Nanox.CLOUD for data management; Nanox.MARKETPLACE and USARAD Holdings for teleradiology services; and Nanox Health IT for workflow solutions. By combining hardware, software, AI, and clinical expertise, Nanox aims to expand access to imaging and improve early disease detection.
This financing will support Nanox's ongoing efforts to commercialize its technology and expand its reach. For the full press release, visit https://ibn.fm/5fNi8. More about Nanox can be found at https://www.nanox.vision/. The announcement was disseminated by InvestorWire, a platform within the Dynamic Brand Portfolio @ IBN.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Nano-X Imaging Raises $8M in Registered Direct Offering
